Fundraising Fox

Provista Diagnostics

Scottsdale, US · Founded 2009 · Delaware corporation

Biotech

Founders & leadership

JF
John FermanisExecutive
DR
David ReeseExecutive
WG
William GartnerinExecutive Vice President

Board

JM
John MacaskillBoard director
TM
Thomas MendellBoard director
YN
Yoji NimuraBoard director
JZ
John ZicarelliBoard director
JG
Jeffrey GilmanBoard director
JL
Jack LevineBoard director
RH
Robert HaririBoard director
AB
Anne BusquetBoard director

Reported raises · per SEC filings

Form D private placements

$32.6M disclosed across 8 rounds · 2012–2018

▶$2.2MraisedMay 2018 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jack LevineDirector
  • John FermanisExecutive Officer
  • John MacaskillDirector
  • Cynthia CollinsDirector
  • John ZicarelliDirector
  • Rao MulpuriExecutive Officer
  • Robert J. HaririDirector
  • Thomas G. MendellDirector
  • Gary AltmanExecutive Officer, Director
  • Jeffrey R. GilmanDirector
  • Yoji NimuraDirector
  • Uriel E. KusiatinExecutive Officer
Offering amount
$5M
Amount sold
$2.2M
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedSep 2017 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey GilmanDirector
  • John MacaskillDirector
  • Anne BusquetDirector
  • Robert HaririDirector
  • John ZicarelliDirector
  • Jack LevineDirector
  • Thomas MendellDirector
  • Uriel E. KusiatinExecutive Officer
  • David ReeseExecutive Officer, Director
  • Yoji NimuraDirector
Offering amount
$4M
Amount sold
$2.3M
First sale
Jul 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedOct 2016 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas MendellDirector
  • Jack LevineDirector
  • Jeffrey GilmanDirector
  • John MacaskillDirector
  • Yoji NimuraDirector
  • John ZicarelliDirector
  • Robert HaririDirector
  • Anne BusquetDirector
  • David ReeseExecutive Officer, Director
  • Uriel E. KusiatinExecutive Officer
Offering amount
$6M
Amount sold
$2.6M
First sale
Oct 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedMar 2016 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Uriel KusiatinExecutive Officer
  • Anne BusquetDirector
  • Jeffrey GilmanDirector
  • David ReeseExecutive Officer, Director
  • John MacaskillDirector
  • John ZicarelliDirector
  • Thomas MendellDirector
  • Robert HaririDirector
  • Jack LevineDirector
  • Yoji NimuraDirector
Offering amount
$5.1M
Amount sold
$5.1M
Minimum investment
$862
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedAug 2015 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey GilmanDirector
  • Anne BusquetDirector
  • Yoji NimuraDirector
  • Thomas MendellDirector
  • John ZicarelliDirector
  • John MacaskillDirector
  • David ReeseExecutive Officer, Director
  • John FermanisExecutive Officer
  • Robert HaririDirector
  • Jack LevineDirector
Offering amount
$6M
Amount sold
$6M
Minimum investment
$261
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.9MraisedMar 2015 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John MacaskillDirector
  • John FermanisExecutive Officer
  • Thomas MendellDirector
  • Jack LevineDirector
  • Yoji NimuraDirector
  • John ZicarelliDirector
  • Robert HaririDirector
  • David ReeseExecutive Officer, Director
  • Anne BusquetDirector
  • Jeffrey GilmanDirector
Offering amount
$3.9M
Amount sold
$3.9M
Minimum investment
$20.2K
First sale
Feb 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedApr 2014 · 34 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey GilmanDirector
  • Robert HaririDirector
  • Jack LevineDirector
  • John ZicarelliDirector
  • John MacaskillDirector
  • David ReeseExecutive Officer, Director
  • John FermanisExecutive Officer
  • Anne BusquetDirector
Offering amount
$6M
Amount sold
$6M
Minimum investment
$920
First sale
Apr 2014
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedMar 2012 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David ReeseExecutive Officer, Director
  • John ZicarelliDirector
  • William GartnerExecutive Officer
  • Jack LevineDirector
  • John FermanisExecutive Officer
  • Robert HaririDirector
  • John MacaskillDirector
  • Anne BusquetDirector
  • Jeffrey GilmanDirector
Offering amount
$5M
Amount sold
$4.5M
Minimum investment
$25K
Proceeds to insiders
$52K
First sale
Feb 2012
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Provista Diagnostics Announces the Closing of $6.0 Million Financingglobenewswire.com · Aug 2015Provista Dx Raises $6M | GenomeWebgenomeweb.com · Aug 2015Provista Dx Raises $3.9M | GenomeWebgenomeweb.com · Mar 2015Provista Diagnostics attracts $6 mlnventurecapitaljournal.com · Apr 2014

Frequently asked questions

How much funding has Provista Diagnostics raised?
Provista Diagnostics has disclosed $32.6M raised across 8 rounds.
Where is Provista Diagnostics headquartered?
Provista Diagnostics is headquartered in Scottsdale, US.